← Back to Search

Diagnostic Test

Biospecimen Collection for COVID-19 (END CoV-2 Trial)

N/A
Waitlist Available
Led By Kathleen M Schmeler
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at a new way to test for SARS-CoV-2, the virus that causes COVID-19. The hope is that this will improve testing for the disease.

Eligible Conditions
  • COVID-19

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Concordance of the novel point-of-care diagnostic test
Negative predictive value (NPV) of the novel point-of-care diagnostic test
Positive predictive value (PPV) of the novel point-of-care diagnostic test
+2 more
Secondary study objectives
Disease progression
Viral load metrics

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (biospecimen collection)Experimental Treatment2 Interventions
Participants undergo collection of nasopharyngeal (back of the nose) samples by a medical provider and self-collection of oral, saliva, and nasal samples.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 3
~2020

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,064 Previous Clinical Trials
1,800,569 Total Patients Enrolled
17 Trials studying COVID-19
76,270 Patients Enrolled for COVID-19
National Cancer Institute (NCI)NIH
13,910 Previous Clinical Trials
41,011,309 Total Patients Enrolled
39 Trials studying COVID-19
1,891,591 Patients Enrolled for COVID-19
William Marsh Rice UniversityOTHER
47 Previous Clinical Trials
27,898 Total Patients Enrolled
~46 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top